Maven Income & Growth VCT (MIG1) Stock Chart & Stock Price History → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free MIG1 Stock Alerts GBX 38 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsDividendInsider TradesStock AnalysisChartCompetitorsDividendInsider Trades Maven Income & Growth VCT Stock Price Performance5 Day Performance0.00%1 Month PerformanceN/A3 Month Performance0.00%6 Month Performance0.00%Year-To-Date Performance0.00%1 Year Performance-7.32% Receive MIG1 Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Maven Income & Growth VCT and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> MIG1 Stock Chart for Thursday, April, 25, 2024 MIG1 Chart by TradingView Maven Income & Growth VCT Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024GBX 38GBX 38GBX 38GBX 3710,336 shs£57.26 million04/23/2024GBX 38GBX 38GBX 38GBX 3720,676 shs£57.26 million04/19/2024GBX 37GBX 38+2.70%GBX 38GBX 371,052 shs£57.26 million04/18/2024GBX 38GBX 37-2.63%GBX 37GBX 371,052 shs£55.75 million04/17/2024GBX 38GBX 38GBX 38GBX 386,201 shs£57.26 million04/16/2024GBX 37GBX 38+2.70%GBX 38GBX 376,201 shs£57.26 million Get the Latest News and Ratings for MIG1 and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Maven Income & Growth VCT and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024GBX 38GBX 37-2.63%GBX 37GBX 376,202 shs£55.75 million04/12/2024GBX 38GBX 38GBX 38GBX 3712,255 shs£57.26 million04/11/2024GBX 37GBX 38+2.70%GBX 39GBX 374,113 shs£57.26 million04/10/2024GBX 38GBX 37-2.63%GBX 39GBX 374,114 shs£55.75 million04/09/2024GBX 38GBX 38GBX 38GBX 3773,783 shs£57.26 million04/08/2024GBX 38GBX 38GBX 38GBX 3773,784 shs£57.26 million04/05/2024GBX 38GBX 38GBX 38GBX 388,590 shs£57.26 million04/04/2024GBX 38GBX 38GBX 38GBX 388,590 shs£57.26 million04/03/2024GBX 37GBX 38+2.70%GBX 38GBX 378,590 shs£57.26 million04/02/2024GBX 38GBX 37-2.63%GBX 37GBX 378,590 shs£55.75 million03/28/2024GBX 37GBX 38+2.70%GBX 38GBX 378,000 shs£57.26 million03/27/2024GBX 38GBX 37-2.63%GBX 37GBX 378,000 shs£55.75 million03/22/2024GBX 38GBX 38GBX 38GBX 375,181 shs£57.26 million03/21/2024GBX 38GBX 38GBX 38GBX 375,182 shs£57.26 million03/15/2024GBX 38GBX 38GBX 38GBX 38100 shs£57.26 million03/14/2024GBX 38GBX 38GBX 38GBX 38100 shs£57.26 million03/13/2024GBX 38GBX 38GBX 38GBX 37100 shs£57.26 million03/12/2024GBX 38GBX 38GBX 38GBX 37200 shs£57.26 million03/08/2024GBX 38GBX 38GBX 38GBX 381,499 shs£57.26 million03/07/2024GBX 38GBX 38GBX 38GBX 371,499 shs£57.26 million03/06/2024GBX 37GBX 38+2.70%GBX 38GBX 372,998 shs£57.26 million03/05/2024GBX 40.91GBX 37-9.55%GBX 37GBX 371,781 shs£55.75 million03/01/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 million02/29/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 million02/28/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 million02/27/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 million02/26/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 million02/23/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 million02/22/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 million02/21/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 million02/20/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 million02/19/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 million02/16/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 million02/15/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>02/14/2024GBX 38GBX 38GBX 38GBX 385,111 shs£57.26 million02/13/2024GBX 39GBX 38-2.56%GBX 38GBX 385,111 shs£57.26 million02/12/2024GBX 39GBX 39GBX 39GBX 375,111 shs£58.76 million02/09/2024GBX 38GBX 39+2.63%GBX 39GBX 375,111 shs£58.76 million02/08/2024GBX 38GBX 38GBX 38GBX 371,000 shs£57.26 million02/07/2024GBX 37GBX 38+2.70%GBX 38GBX 372,000 shs£57.26 million02/06/2024GBX 38GBX 37-2.63%GBX 37GBX 371,000 shs£55.75 million02/05/2024GBX 38GBX 38GBX 38GBX 371,000 shs£57.26 million02/02/2024GBX 37GBX 37GBX 37GBX 371,000 shs£54.68 million02/01/2024GBX 37GBX 37GBX 37GBX 378,500 shs£54.68 million01/31/2024GBX 37.60GBX 37-1.60%GBX 37GBX 371,037 shs£54.68 million01/30/2024GBX 37GBX 37.60+1.62%GBX 37.60GBX 37.60689,339 shs£55.57 million01/29/2024GBX 38GBX 37-2.63%GBX 37GBX 371,000 shs£54.68 million01/26/2024GBX 38GBX 38GBX 38GBX 375,541 shs£56.16 million01/25/2024GBX 38GBX 38GBX 38GBX 372,000 shs£56.16 million01/24/2024GBX 37GBX 38+2.70%GBX 38GBX 371,000 shs£56.16 million Related Companies: SBO Stock Chart AEET Stock Chart MIG Stock Chart EJFI Stock Chart CMPI Stock Chart MIG3 Stock Chart MIG5 Stock Chart AAVC Stock Chart ASCI Stock Chart BEMO Stock Chart Receive MIG1 Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maven Income & Growth VCT and its competitors with MarketBeat's FREE daily newsletter. This page (LON:MIG1) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maven Income & Growth VCT Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.